Plenary Session
Session 1 - The 2026 Heart Failure Guidelines: What Will Change My Practice
Chairs: Andrew Coats, Sotiria Liori
-
New Definitions, Classification and the Updated Diagnostic Pathway - Marco Metra
-
GDMT Sequencing and Rapid Up-Titration: From STRONG-HF to Routine Care - Mattia Arrigo
-
Foundational Therapy Across the Ejection-Fraction Spectrum - Maja Cikes
-
GDMT and Device Therapies - Rudolf De Boer
-
Panel Discussion
Meet the Expert
Functional Regurgitation (FRM) in Patients With Heart Failure: Unmet Needs and Future Perspectives
Chair: Stefan Anker
Welcome - Stefan Anker
FMR in Heart Failure: Two Phenotypes (Ventricular and Atrial FMR), One Unmet Need - Alper Öner
Future Perspectives: Indirect Annuloplasty With Carillon in Real-World Practice - Peter Nordbeck
Discussion: Tailoring Treatment: Which Patient, Which Phenotype, Which Intervention?
Close - Stefan Anker
Supported by an unrestricted educational grant from Cardiac Dimensions
Plenary Session
Session 2 - HFrEF in 2026: Beyond the Four Pillars
Chairs: Mitja Lainscak, Dirk van Veldhuisen
-
The Four Pillars in Real-World Practice: Are We Actually There Yet? - Lisa Anderson
-
Digitoxin After DIGIT-HF: Back on the Table? - Johann Bauersachs
-
Vericiguat After VICTOR: Who Benefits, and When? - Faiez Zannad
-
HFimpEF: Recovery, Remission and the Case for (Not) Withdrawing Therapy - Ankeet Bhatt
-
Panel Discussion
Symposium
Symposium: Implementing 2026 Heart Failure Guidelines Management of Iron Deficiency Along the Patient’s Journey
Chairs: Piotr Ponikowski, Mitja Lainscak
Welcome - Piotr Ponikowski
Guidelines for the Management of Iron Deficiency in Heart Failure – Definition, Screening, and Treatment -Daniela Tomasoni
Benefits of Intravenous Iron Therapy in Patients With HFrEF - Insights From an Individual-Patient-Data Meta-Analysis – John Cleland
Management of Iron Deficiency Along the Patient’s Journey – Translating Evidence Into Clinical Practice – Gianluigi Savarese
Panel Discussion and Q&A - All
Close - Piotr Ponikowski
Supported by an unrestricted educational grant from CSL Vifor
Plenary Session
Session 3 - Cardiorenal Syndrome in 2026
Chairs: Shahzeb Khan, Francesca Musella
-
Beyond eGFR: Assessing and Monitoring Kidney Risk in Heart Failure - James Burton
-
Chronic Kidney Disease in HF: Managing the Overlap - Ana Cebrián Cuenca
-
Hyperkalaemia as a Barrier to Guideline-Directed Therapy - Tina Marvasti
-
Potassium Binders and Finerenone: Enabling and Protecting RAAS/MRA Therapy - Hiddo Heerspink
-
Panel Discussion
Meet the Expert
Implementing SGLT2 Inhibitors Across The Heart Failure Continuum: From Prevention to Advanced Disease
Welcome
Foundational Therapy Across the HF Continuum: SGLT2 Inhibitors From Prevention (Stages A–B) to Established and Advanced Heart Failure (Stages C–D) - Javed Butler
From Evidence to Implementation: Start Early, Combine Rapdly, Persist - Biykem Bozkurt
Panel Discussion
Close
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 4 - HFpEF: One Syndrome, Many Phenotypes
Chairs: Shahzeb Khan, Abhinav Gupta
Finding HFpEF Earlier: Diagnostic Algorithms and Risk Scores - Cristina Gavina
Foundational Therapy in HFpEF: SGLT2 Inhibitors and Finerenone (FINEARTS-HF) - Muthiah Vaduganathan
Interaction Between MASLD: MASH & HFpEF: A Clinical Reality - Melanie Paillard
Arrhythmias in HFpEF - Javed Butler
Panel Discussion
Plenary Session
Session 5 - CKM Disease and Heart Failure- Obesity is Everywhere
Chair: Donna Ryan, Clara Ines Saldarriaga
-
AHA ACC CKM Guidelines - Chiadi Ndumele
-
Obesity-Related Heart Failure: Mechanisms and Epidemiology - Naveed Sattar
-
The Pipeline: Oral GLP-1, Dual and Triple Agonists - Dame Melanie Davies
-
Weight Loss, Muscle and Body Composition: Protecting the Muscle - Stefan Anker
-
Panel Discussion
Meet the Expert
REPLAY: Functional Regurgitation (FRM) in Patients With Heart Failure: Unmet Needs and Future Perspectives
Chair: Stefan Anker
-
Welcome - Stefan Anker
-
FMR in Heart Failure: Two Phenotypes (Ventricular and Atrial FMR), One Unmet Need - Alper Öner
-
Future Perspectives: Indirect Annuloplasty With Carillon in Real-World Practice - Peter Nordbeck
-
Discussion: Tailoring Treatment: Which Patient, Which Phenotype, Which Intervention?
-
Close - Stefan Anker
Supported by an unrestricted educational grant from Cardiac Dimensions
Plenary Session
Session 6 - Cardiomyopathies and Cardiac Amyloidosis in 2026
Chairs: Shahzeb Khan, Wilhelm Haverkamp
A Rational Diagnostic Pathway for the Cardiomyopathies - Arnt Kristen
Cardiac Amyloidosis: When to Suspect and How to Confirm - Fabian Knebel
ATTR-CM Therapies: Stabilisers, Silencers and What Comes Next - Laura Obici
Hypertrophic Cardiomyopathy: Cardiac Myosin Inhibitors in Practice - Ahmad Masri
Panel Discussion
Plenary Session
Session 7 - Rhythm Management and Device Therapies in Heart Failure
Chairs: John Cleland, Stefan Anker
-
Sudden Cardiac Death Prevention in HFrEF: Is the ICD Still Needed in 2026? - Shahzeb Khan
-
CRT and Conduction System Pacing: Choosing the Right Strategy - Amr Abdin
-
Cardiac Contractility Modulation and Device-Based Neuromodulation - Jürgen Kuschyk
-
Interatrial Shunt Devices and Sleep-Disordered Breathing: Where Do They Fit? - William Abraham
-
Panel Discussion
Meet the Expert
REPLAY: Implementing SGLT2 Inhibitors Across The Heart Failure Continuum: From Prevention to Advanced Disease
Welcome
Foundational Therapy Across the HF Continuum: SGLT2 Inhibitors From Prevention (Stages A–B) to Established and Advanced Heart Failure (Stages C–D) - Javed Butler
From Evidence to Implementation: Start Early, Combine Rapdly, Persist - Biykem Bozkurt
Panel Discussion
Close
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 8 - Valvular Heart Disease in Heart Failure
Chair: Karl-Patrik Kresoja, Antonio Cannata
-
Functional Mitral Regurgitation: TEER and the Evolving Evidence - Gregg Stone
-
Tricuspid Regurgitation in HF: Repair, Replacement or Medical Therapy - Erwan Donal
-
Carillon for Functional MR: Patient Selection and Place in Therapy - Klaus Witte
-
The Heart Team Approach to the Heart Failure Patient - Karl Toischer
-
Panel Discussion
Meet the Expert
Non-Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Which Patients, When to Initiate and How to Follow-Up?
-
Welcome - Maja Cikes
-
Which Heart Failure Patient Benefit From nsMRAs? - Muthiah Vaduganathan
-
How to Initiate and Follow-up HF Patients on nsMRAs? - Maja Cikes
-
Panel Discussion and Q&A
-
Close - Muthiah Vaduganathan
Supported by an unrestricted educational grant from Bayer
Plenary Session
Session 9 - Significant Problem of Vulnerable HF Patient
Chairs: Ovidiu Chioncel, Ewa Jankowska
-
Optimizing Heart Failure Care in Older Patients - Harriette van Spall
-
Iron Deficiency Across the EF Spectrum: FAIR-HF2 and the Meta-Analytic Picture - Piotr Ponikowski
-
Advanced HF: Recognising the Tipping Point and Getting Referral Timing Right - Maria Crespo-Leiro
-
LVAD and Transplant in the Modern Era: Candidacy and Outcomes - Mandeep Mehra
-
Panel Discussion
Meet the Expert
Two Numbers, One Foundational Therapy: eGFR, UACR and SGLT2 Inhibitors Patients with HF and CKD
-
Welcome
-
Two Numbers That Matter: Screening for CKD With eGFR and UACR in Patients With Heart Failure - James Burton
-
One Foundational Therapy: SGLT2 Inhibitors Across the eGFR Spectrum - From EMPA-KIDNEY to Integrated Cardiorenal Care - Shelley Zieroth
-
Panel Discussion and Q&A
-
Close
Supported by an unrestricted educational grant from Boehringer Ingelheim
Plenary Session
Session 10 - Delivering Better Heart Failure Care and Innovation in 2026
Chairs: Shelley Zieroth, Fausto Pinto
-
Telemonitoring and Remote Management: What Works and for Whom - Nicolas Girerd
-
Polypharmacy, Adherence and Persistence: The Implementation Reality - Giuseppe Rosano
-
Multidisciplinary HF Care and Transitions of Care - Tiny Jaarsma
-
Preventing Heart Failure - Norbert Frey
-
Panel Discussion
Amr Abdin
University Hospital of Saarland, Homburg, DE
William Abraham
The Ohio State University Wexner Medical Center, Columbus, US
Lisa Anderson
St George’s Hospital, London, UK
Stefan Anker
Charite University Hospital, Berlin, DE
Mattia Arrigo
Ospedale Regionale di Lugano, Lugano, CH
Johann Bauersachs
Hannover Medical School, Hannover, DE
Ankeet Bhatt
Kaiser San Francisco Medical Center, San Francisco, US
Biykem Bozkurt
Baylor College of Medicine, Houston, US
James Burton
University of Leicester, Leicester, UK
Javed Butler
Baylor Scott & White Health, Dallas, US
Antonio Cannata
King's College London, London, UK
Ovidiu Chioncel
University of Medicine Carol Davila, Bucharest, RO
Maja Cikes
University of Zagreb School of Medicine, Zagreb, HR
John Cleland
University of Glasgow, Glasgow, UK
Andrew Coats
Heart Research Institute, Sydney, AU
Maria Crespo-Leiro
University of A Coruña (UDC), Coruna, ES
Ana Cebrián Cuenca
Murcian Health Service, Cartagena , ES
Dame Melanie Davies
University of Leicester, Leicester, UK
Rudolf De Boer
University of Groningen, Groningen, NL
Gerasimos Filippatos
Attikon University Hospital, Athens, GR
Marianna Fontana
University College London (UCL), London, UK
Norbert Frey
University of Heidelberg, Heidelberg, DE
Cristina Gavina
University of Porto, Porto, PT
Nicolas Girerd
University Hospital of Nancy, Nancy, FR
Abhinav Gupta
Acharya Shri Chander College of Medical Sciences and Hospital (ASCOMS), Jammu, IN
Wilhelm Haverkamp
Charite University Hospital, Berlin, DE
Hiddo Heerspink
University of Groningen, Groningen, NL
Tiny Jaarsma
Linköping University, Linköping, SE
Ewa Jankowska
Wrocław Medical University, Wroclaw, PL
Shahzeb Khan
Baylor Scott & White Health, Texas, US
Prof Fabian Knebel
Sana Klinikum Lichtenberg, Berlin, DE
Karl-Patrik Kresoja
University Medical Centre of the Johannes Gutenberg University, Mainz, DE
Arnt Kristen
University of Heidelberg, Heidelberg, DE
Jürgen Kuschyk
Mannheim, DE
Mitja Lainscak
University of Ljubljana, Ljubljana, SI
Tina Marvasti
University of Toronto, Toronto, CA
Ahmad Masri
Oregon Health & Science University Medical Group, Portland, US
Mandeep Mehra
Brigham and Women's Hospital, Boston, US
Marco Metra
University of Brescia, Bresica, IT
Francesca Musella
Karolinska Institute, Stockholm, SE
Chiadi Ndumele
Johns Hopkins University, Baltimore, US
Laura Obici
IRCCS Fondazione Policlinico San Matteo, Pavia, IT
Fausto Pinto
Santa Maria University Hospital, Lisbon, PT
Piotr Ponikowski
Wroclaw Medical University, Wroclaw, PL
Giuseppe Rosano
St George's University Medical School, London, UK
Donna Ryan
Pennington Biomedical Research Center, Baton Rouge, US
Clara Ines Saldarriaga
University of Antioquia, Medellín, CO
Naveed Sattar
University of Glasgow, Glasgow, UK
Gianluigi Savarese
Karolinska Institutet, Stockholm, SE
Gregg Stone
Mount Sinai Heart Health System, New York, US
Karl Toischer
University of Göttingen, Göttingen, DE
Daniela Tomasoni
Civil Hospital of Brescia, Brescia, IT
Muthiah Vaduganathan
Brigham and Women's Hospital, Boston, US
Peter van der Meer
University of Groningen, Groningen, NL
Harriette Van Spall
McMaster University, Hamilton, CA
Dirk van Veldhuisen
University of Groningen, Groningen, NL
Klaus Witte
University of Leeds, Leeds, UK
Faiez Zannad
University of Lorraine, Nancy, FR
Shelley Zieroth
University of Manitoba, Winnipeg, CA
